Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Toni K. Choueiri"'
Autor:
Toni K. Choueiri, Thomas Powles, Laurence Albiges, Mauricio Burotto, Cezary Szczylik, Bogdan Zurawski, Eduardo Yanez Ruiz, Marco Maruzzo, Alberto Suarez Zaizar, Luis E. Fein, Fabio A. Schutz, Daniel Y.C. Heng, Fong Wang, Fabio Mataveli, Yu-Lin Chang, Maximiliano van Kooten Losio, Cristina Suarez, Robert J. Motzer
Publikováno v:
New England Journal of Medicine. 388:1767-1778
Autor:
Toni K, Choueiri, Thomas, Powles, Mauricio, Burotto, Bernard, Escudier, Maria T, Bourlon, Bogdan, Zurawski, Victor M, Oyervides Juárez, James J, Hsieh, Umberto, Basso, Amishi Y, Shah, Cristina, Suárez, Alketa, Hamzaj, Jeffrey C, Goh, Carlos, Barrios, Martin, Richardet, Camillo, Porta, Rubén, Kowalyszyn, Juan P, Feregrino, Jakub, Żołnierek, David, Pook, Elizabeth R, Kessler, Yoshihiko, Tomita, Ryuichi, Mizuno, Jens, Bedke, Joshua, Zhang, Matthew A, Maurer, Burcin, Simsek, Flavia, Ejzykowicz, Gisela M, Schwab, Andrea B, Apolo, Robert J, Motzer, Suresh, Nair
Publikováno v:
New England Journal of Medicine. 384:829-841
The efficacy and safety of nivolumab plus cabozantinib as compared with those of sunitinib in the treatment of previously untreated advanced renal-cell carcinoma are not known.In this phase 3, randomized, open-label trial, we randomly assigned adults
Autor:
David I. Quinn, Toni K. Choueiri, Stéphane Culine, Joaquim Bellmunt, Daniel P. Petrylak, Howard Gurney, Nicholas J. Vogelzang, Dean F. Bajorin, Ronald de Wit, Christian Heinrich Poehlein, Yabing Mai, Miguel Angel Climent, Lawrence Fong, David J. Vaughn, Andrea Necchi, Yves Fradet, Cora N. Sternberg, Jae-Lyun Lee, Rodolfo F. Perini, Winald R. Gerritsen
Publikováno v:
New England Journal of Medicine, 376(11), 1015-1026. Massachussetts Medical Society
The New England Journal of Medicine, 376, 1015-1026
The New England Journal of Medicine, 376, 11, pp. 1015-1026
The New England Journal of Medicine, 376, 1015-1026
The New England Journal of Medicine, 376, 11, pp. 1015-1026
Contains fulltext : 170338.pdf (Publisher’s version ) (Open Access) Background Patients with advanced urothelial carcinoma that progresses after platinum-based chemotherapy have a poor prognosis and limited treatment options. Methods In this open-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47c673d0d6ae5770552bfe787b20a4bb
http://hdl.handle.net/10230/33797
http://hdl.handle.net/10230/33797